ATOSSA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ATOSSA THERAPEUTICS, INC. (ATOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 890 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 890.00 shares, a 33.03% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was -3.21K shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 139.00 shares, a 50.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 229.00 shares, a 95.03% decline from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 4.61K shares, a 2.81% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 4.74K shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 890.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 890.00 shares 10-Q · filed 2026-08-07 | -2.32K shares derived: sum of 3 quarters · filed 2026-08-07 | -2.18K shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | -3.21K shares derived: sum of 2 quarters · filed 2026-05-08 | -3.07K shares derived: sum of 3 quarters · filed 2026-05-08 | -2.40K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | -3.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -3.07K shares derived: sum of 2 quarters · filed 2026-03-25 | -2.40K shares derived: sum of 3 quarters · filed 2026-03-25 | 229.00 shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 139.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 808.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 3.44K shares 10-Q · filed 2025-11-12 | 3.44K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 669.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 3.30K shares 10-Q · filed 2025-08-12 | 3.30K shares derived: sum of 3 quarters · filed 2025-08-12 | 3.57K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 2.63K shares 10-Q · filed 2025-05-13 | 2.63K shares derived: sum of 2 quarters · filed 2025-05-13 | 2.90K shares derived: sum of 3 quarters · filed 2025-05-13 | 6.35K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 278.00 shares derived: sum of 2 quarters · filed 2025-03-25 | 3.73K shares derived: sum of 3 quarters · filed 2025-03-25 | 4.61K shares 10-K · filed 2025-03-25 |
| 2024-09-30 | 278.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 3.73K shares derived: sum of 2 quarters · filed 2024-11-12 | 4.61K shares 10-Q · filed 2024-11-12 | 5.34K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 3.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 4.33K shares 10-Q · filed 2024-08-12 | 5.07K shares derived: sum of 3 quarters · filed 2024-08-12 | 5.07K shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 880.00 shares 10-Q · filed 2024-05-13 | 1.62K shares derived: sum of 2 quarters · filed 2024-05-13 | 1.62K shares derived: sum of 3 quarters · filed 2024-05-13 | 2.62K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 739.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 739.00 shares derived: sum of 2 quarters · filed 2024-04-01 | 1.74K shares derived: sum of 3 quarters · filed 2024-04-01 | 4.74K shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 1.00K shares derived: sum of 2 quarters · filed 2023-11-13 | 4.00K shares 10-Q · filed 2023-11-13 | 4.00K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 4.00K shares 10-Q · filed 2023-08-14 | 4.00K shares derived: sum of 3 quarters · filed 2023-08-14 | 4.00K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 3.00K shares 10-Q · filed 2023-05-15 | 3.00K shares derived: sum of 2 quarters · filed 2023-05-15 | 3.00K shares derived: sum of 3 quarters · filed 2023-05-15 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-22 | 0.00 shares 10-K · filed 2023-03-22 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 0.00 shares 10-Q · filed 2022-11-07 | ||
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-08 | |||
| 2021-12-31 | -223.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 0.00 shares derived: sum of 2 quarters · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | 223.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 223.00 shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-13 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-08 | 0.00 shares derived: sum of 3 quarters · filed 2018-03-08 | 19.08K shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-13 | 19.08K shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 19.08K shares 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | 19.08K shares 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 350.00K shares 10-K · filed 2016-03-30 | ||
| 2015-09-30 | 350.00K shares 10-Q · filed 2015-11-12 | |||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-14 | -2.19K shares derived: sum of 2 quarters · filed 2014-05-14 | 1.63K shares derived: sum of 3 quarters · filed 2014-05-14 | 1.63K shares derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | -2.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | 1.63K shares derived: sum of 2 quarters · filed 2014-03-27 | 1.63K shares derived: sum of 3 quarters · filed 2014-03-27 | 1.63K shares 10-K · filed 2014-03-27 |
| 2013-09-30 | 3.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 3.81K shares derived: sum of 2 quarters · filed 2013-11-12 | 3.81K shares 10-Q · filed 2013-11-12 | 3.81K shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 0.00 shares 10-Q · filed 2013-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2013-08-14 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2013-05-15 | ||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | 0.00 shares 10-K · filed 2013-03-28 | ||
| 2012-09-30 | 0.00 shares 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |